Home > Journals > International Angiology > Past Issues > International Angiology 2016 February;35(1) > International Angiology 2016 February;35(1):62-70

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

INTERNATIONAL ANGIOLOGY

A Journal on Angiology


Official Journal of the International Union of Angiology, the International Union of Phlebology and the Central European Vascular Forum
Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,899


eTOC

 

ORIGINAL ARTICLES  


International Angiology 2016 February;35(1):62-70

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

Can the tandem measurement of age adjusted D-dimer and tissue plasminagen activator improve the clinical utility of a conventional D-dimer in the pulmonary embolism diagnosis?

Julio FLORES 1, 2, Angel GARCÍA-AVELLO 3, Antonio RUÍZ 1, Esther ALONSO 1, Concepción ÁLVAREZ 4, Olga NAVARRETE 1, Ignacio ARRIBAS 2, 5

1 Section of Pneumology, Príncipe de Asturias University Hospital, Alcalá de Henares, Madrid, Spain; 2 Departament of Medicine, Faculty of Medicine, University of Alcalá, Alcalá de Henares, Madrid, Spain; 3 Service of Hematology and Hemotherapy, Ramón y Cajal University Hospital, Madrid, Spain; 4 Service of Radiodiagnostics, Príncipe de Asturias University Hospital, Alcalá de Henares, Spain; 5 Biomedical Investigation Foundation, Príncipe de Asturias University Hospital, Alcalá de Henares, Madrid, Spain


PDF  


BACKGROUND: The aim of this study was to evaluate if a sequential measurement of age adjust D-dimer (ADD) and tissue plasminogen activator (tPA) could increase the clinical utility in patients with suspected pulmonary embolism (PE) compared to a conventional D-dimer.
METHODS: We measured a conventional D-dimer (CDD), an ADD alone and a sequential combination ADD and tPA (ADD/tPA combination) in a prospective sample of 127 outpatients with PE suspected. Diagnosis of PE was based on a strict protocol. Plasma sample to measure levels of tPA and D-dimer was obtained at enrollment, and CDD, ADD and tPA were assessed at the end of study. For CDD the cut-off value was 500 ng/mL and for ADD the cut-off value was defined as (patient’s age x10) ng/mL in patients aged >50. We compared the sensitivity, specificity and clinical utility obtained for CDD, ADD alone, and ADD/tPA combination.
RESULTS: PE was confirmed in 41 patients (32%). The sensitivity, specificity and clinical utility for CDD were 95%, 36% and 28%, respectively. The ADD/tPA combination and ADD alone demonstrated an increased in specificity of +29% and +12% respectively, and increased in clinical utility of +20% and +8%, respectively, compared to CDD, and this was obtained without loss of sensitivity.
CONCLUSION: The ADD/tPA combination substantially increased the clinical utility in the PE diagnosis compared with conventional D-dimer, without reducing the security. The ADD/tPA combination could decrease the need for pulmonary vascular imaging for the PE diagnosis in nearly the half. These promising results should be validated prospectively.

top of page

Publication History

Cite this article as

Corresponding author e-mail

jflores.hupa@salud.madrid.org